Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr 7;7(1):118.
doi: 10.1038/s41392-022-00965-5.

Omicron: Master of immune evasion maintains robust ACE2 binding

Affiliations
Comment

Omicron: Master of immune evasion maintains robust ACE2 binding

Markus Hoffmann et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
ACE2 interactions and resistance against antibody-mediated neutralization of the Omicron spike protein. a Left panel: Model of the trimeric SARS-CoV-2 spike protein bound to ACE2 (red). Right panel: Close-up on the binding interface of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein (violet) and ACE2 (green). RBD residues that are mutated in the Omicron variant sublineage (BA.1) are highlighted (red). b Individual and combined impact of Omicron-specific RBD mutations. Omicron residues that establish new interactions with ACE2 are highlighted (gray). c Relative ACE2 binding by the spike proteins of wild-type (WT) SARS-CoV-2 and SARS-CoV-2 variants Delta and Omicron. d Convalescent and vaccinee sera exhibit low neutralization potency against the Omicron variant. e The Omicron variant is resistant against most monoclonal antibodies (mAbs) that neutralize WT SARS-CoV-2 with high potency.

Comment on

References

    1. Mannar, D. et al. SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science10.1126/science.abn7760 (2022). - PMC - PubMed
    1. Zhang, J. et al. Structural and functional impact by SARS-CoV-2 Omicron spike mutations. bioRxiv10.1101/2022.01.11.47592 (2022). - PMC - PubMed
    1. McCallum, M. et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science10.1126/science.abn8652 (2022). - PMC - PubMed
    1. Hoffmann M, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022;185:447–456.e411. doi: 10.1016/j.cell.2021.12.032. - DOI - PMC - PubMed
    1. Lamers, M. M. et al. SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium. bioRxiv10.1101/2022.01.19.476898 (2022).

Publication types

Substances